-
Mashup Score: 9
Congenital thrombotic thrombocytopenic purpura (TTP) results from severe hereditary deficiency of ADAMTS13. The efficacy and safety of recombinant ADAMTS13 and standard therapy (plasma-derived prod…
Source: www.nejm.orgCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 0Climate Change and Mental Health - 2 day(s) ago
This JAMA Insights discusses the adverse effects of climate change on mental health and proposes solutions to help mitigate those effects.
Source: jamanetwork.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 1
This cohort study describes the long-term outcomes of PE in 150 children and adolescents followed-up at a single-center institution.Patients were screened for a
Source: ashpublications.orgCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 0
It has been replaced by a new model, which will be used in automotive manufacturing. A farewell video featured the old machine running outdoors, performing back flips and awkwardly shimmying.
Source: www.nytimes.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 2France needs a chief science adviser - 13 day(s) ago
France is at a crossroads, facing environmental and social challenges that are profoundly altering its society. Yet, the French government keeps prioritizing short-term political gains over long-term evidence-based planning for major transitions that …
Source: www.science.orgCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 9Is there a role for the laboratory monitoring in the management of specific antidotes of direct oral anticoagulants? - 19 day(s) ago
Given the growing number of patients receiving direct oral anticoagulant (DOAC), patients requiring rapid neutralization is also increasing in case of major bleedings or urgent surgery/procedures. Idarucizumab is commercialized as a specific antidote to dabigatran while andexanet alfa has gained the Food and Drug Administration and the European Medicines Agency approval as an oral anti-factor Xa inhibitors antidote. Other antidotes or hemostatic agents are still under preclinical or clinical development, the most advanced being ciraparantag.
Source: www.thrombosisresearch.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 4MEDVASC - Réversion AOD : case départ ! - 21 day(s) ago
Blog du Dr Jean-Pierre LAROCHE, médecin vasculaire sans filtre et pragmatique qui parle de Médecine Vasculaire et de l’actualité
Source: medvasc.infoCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 0Another Early Win for TAVI in Low-Risk Patients | NEJM - 23 day(s) ago
Original Article from The New England Journal of Medicine — Another Early Win for TAVI in Low-Risk Patients
Source: www.nejm.orgCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 12Perioperative management of venous recanalization in a patient with inherited antithrombin deficiency - Case Report - 26 day(s) ago
Inherited antithrombin deficiency (ATD) is a severe thrombophilia causing venous thromboembolism, which can be complicated by post-thrombotic syndrome (PTS). Venous recanalization (VR), used to treat PTS, often requires a temporary withdrawal of anticoagulant therapy. In ATD patients, there is a risk of insufficient perioperative anticoagulation due to altered heparin response.
Source: www.rpthjournal.orgCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 14Fibrinogen levels and clot properties identify patients that benefit from catheter-directed thrombolysis after DVT - 1 month(s) ago
Key Points. Baseline fibrin clot lag time, maximal turbidity, fibrinogen and C-reactive protein levels predicted patency one year after iliofemoral DVT.Cat
Source: ashpublications.orgCategories: General Medicine News, Hematologists1Tweet
📰Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura - @NEJM Congrats Marie Scully @coppo_paul #TMA #TTP #VWF https://t.co/BS4OBVsPZT https://t.co/6hsn2BqCO4